Dr. Maria Basile, MD

Dr. Basile practices at Bislr Medical Groups Of Mount Sinai in New York, New York.

Dr. Basile's NPI, 1851595839, was assigned on June 13, 2007. Dr. Basile graduated from SUNY Downstate Health Sciences University in 2003. Dr. Basile holds New York license 237850.

Dr. Basile's primary practice is Bislr Medical Groups of Mount Sinai, at 55 E 34th St Fl 1 Fl 1, New York, NY 10016. The practice phone is (212) 252-6131.

Dr. Basile's primary practice is Bislr Medical Groups Of Mount Sinai in New York, New York. Dr. Basile is also affiliated with New York Eye and Ear Infirmary of Mount Sinai. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Basile to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Basile practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Basile's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Basile is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Basile's licenses on file in 2 states: New York and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Basile treats.

CMS data shows 3,016 Medicare services from Dr. Basile across 18 procedure codes in 2024, for 716 Medicare patients. Medicare paid $253,447 for them.

CMS counts 716 Medicare patients who saw Dr. Basile in 2024. The largest group is 65 to 74, with 342 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Basile's median patient age at 67, with 59% women.

In 2024, Dr. Basile wrote 3,521 Medicare Part D claims for 639 patients. 56% of them were for generic drugs. CMS names the drug for 3,434 of them, across 37 drugs with 11 or more claims each, at $772,264 in total drug cost. In 2023, CMS named 3,276 claims across 37 drugs.

Dr. Basile accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 212 procedures of cataract surgery by Dr. Basile, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Basile in 2024. Dr. Basile's most frequent co-authors are John Danias, MD, PhD, Lisa A. Strano-Paul, MD and Jeffrey Trilling, MD.

CMS Open Payments shows 49 general payments to Dr. Basile from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Allergan Inc. paid the most, $614.

Dmand AI lists 1 award for Dr. Basile, most recently CMS Stage 1 EHR in 2013.

Dr. Basile graduated from SUNY Downstate Health Sciences University in 2003.

Dr. Basile is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.